Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

[Gender and health status response to long-term oxygen therapy in COPD patients].

Coleta KD, Lima DF, Tanni SE, Silveira LV, Godoy I, Godoy I.

Arch Bronconeumol. 2011 Aug;47(8):382-8. doi: 10.1016/j.arbres.2011.03.009. Epub 2011 May 31. Spanish.

2.

Predictors of first-year survival in patients with advanced COPD treated using long-term oxygen therapy.

Coleta KD, Silveira LV, Lima DF, Rampinelli EA, Godoy I, Godoy I.

Respir Med. 2008 Apr;102(4):512-8. doi: 10.1016/j.rmed.2007.12.003. Epub 2008 Jan 10.

3.

Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.

Ambrosino N, Foglio K, Balzano G, Paggiaro PL, Lessi P, Kesten S; Tiotropium Multicentric Italian Study Group.

Int J Chron Obstruct Pulmon Dis. 2008;3(4):771-80.

4.

Predictors of health status do not change over three-year periods and exacerbation makes difference in chronic obstructive pulmonary disease.

Ferrari R, Tanni SE, Caram LM, Naves CR, Godoy I.

Health Qual Life Outcomes. 2011 Dec 9;9:112. doi: 10.1186/1477-7525-9-112.

5.

Gender differences in predictors of health status in patients with COPD.

Ferrari R, Tanni SE, Lucheta PA, Faganello MM, do Amaral RA, Godoy I.

J Bras Pneumol. 2010 Jan-Feb;36(1):37-43. English, Portuguese.

6.

Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.

Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JP.

Clin Ther. 2007 Feb;29(2):261-78.

PMID:
17472819
7.

Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study.

Wang C, Sun T, Huang Y, Humphries M, Bai L, Li L, Wang Q, Kho P, Firth R, D'Andrea P.

Int J Chron Obstruct Pulmon Dis. 2015 Jan 5;10:57-68. doi: 10.2147/COPD.S72650. eCollection 2015. Erratum in: Int J Chron Obstruct Pulmon Dis. 2015;10:1513.

8.

Behavior of Quality of Life (SGRQ) in COPD Patients According to BODE Scores.

Nonato NL, Díaz O, Nascimento OA, Dreyse J, Jardim JR, Lisboa C.

Arch Bronconeumol. 2015 Jul;51(7):315-21. doi: 10.1016/j.arbres.2014.02.017. Epub 2015 Jan 23. English, Spanish.

9.

Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.

Perez T, Burgel PR, Paillasseur JL, Caillaud D, Deslée G, Chanez P, Roche N; INITIATIVES BPCO Scientific Committee.

Int J Chron Obstruct Pulmon Dis. 2015 Aug 18;10:1663-72. doi: 10.2147/COPD.S82408. eCollection 2015.

10.

Effect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trial.

Tashkin D, Celli B, Kesten S, Lystig T, Decramer M.

Respir Med. 2010 Oct;104(10):1495-504. doi: 10.1016/j.rmed.2010.03.033. Epub 2010 Apr 24.

11.

Efficacy and safety of aclidinium bromide in patients with COPD: A phase 3 randomized clinical trial in a Korean population.

Lee SH, Lee J, Yoo KH, Uh ST, Park MJ, Lee SY, Kim JY, Kim DK, Kim SJ, Lee KH, Yoo CG.

Respirology. 2015 Nov;20(8):1222-8. doi: 10.1111/resp.12641. Epub 2015 Sep 15.

12.

Functional capacity, physical activity, and quality of life in hypoxemic patients with chronic obstructive pulmonary disease.

Saglam M, Vardar-Yagli N, Savci S, Inal-Ince D, Calik-Kutukcu E, Arikan H, Coplu L.

Int J Chron Obstruct Pulmon Dis. 2015 Feb 26;10:423-8. doi: 10.2147/COPD.S78937. eCollection 2015.

14.

The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.

Lin YX, Xu WN, Liang LR, Pang BS, Nie XH, Zhang J, Wang H, Liu YX, Wang DQ, Xu ZY, Wang HW, Zhang HS, He ZY, Yang T, Wang C.

Chin Med J (Engl). 2009 Dec 20;122(24):2939-44.

PMID:
20137478
15.
16.

Influence of the oxygen delivery system on the quality of life of patients with chronic hypoxemia.

Tanni SE, Vale SA, Lopes PS, Guiotoko MM, Godoy I, Godoy I.

J Bras Pneumol. 2007 Mar-Apr;33(2):161-7. English, Portuguese.

17.

The Severe Respiratory Insufficiency Questionnaire for Subjects With COPD With Long-Term Oxygen Therapy.

Walterspacher S, July J, Kohlhäufl M, Rzehak P, Windisch W.

Respir Care. 2016 Sep;61(9):1186-91. doi: 10.4187/respcare.04574. Epub 2016 Apr 26.

18.

Long-term oxygen therapy in chronic obstructive pulmonary disease: the use of concentrators and liquid oxygen systems in north-western Greece.

Katsenos S, Charisis A, Daskalopoulos G, Constantopoulos SH, Vassiliou MP.

Respiration. 2006;73(6):777-82. Epub 2006 Jun 30.

PMID:
16825755
19.

Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use.

Decramer M, Dahl R, Kornmann O, Korn S, Lawrence D, McBryan D.

Respir Med. 2013 Feb;107(2):223-32. doi: 10.1016/j.rmed.2012.10.022. Epub 2012 Dec 6.

20.

Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?

Dreyse J, Díaz O, Repetto PB, Morales A, Saldías F, Lisboa C.

Int J Chron Obstruct Pulmon Dis. 2015 Mar 10;10:525-33. doi: 10.2147/COPD.S76475. eCollection 2015.

Supplemental Content

Support Center